• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Technology·BLND
Held by 2 Gurus
Share

Blend Labs, Inc. Stocks

$ 1.04Last Updated 05.10.2026

Issuer Rating

2/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

$ 249.38M

$ 1.04
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Favourable analyst view

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

In Guru Portfolios

Kenneth Griffin

Portfolio Weight (%)

0.0%

Change

-0.00%

Fund

CITADEL ADVISORS LLC

Steven Cohen

Portfolio Weight (%)

0.0%

Change

+0.00%

Fund

Point72 Asset Management, L.P.

Manager
Fund
Portfolio Weight (%)
Change
Kenneth GriffinCITADEL ADVISORS LLC0.0%-0.00%
Steven CohenPoint72 Asset Management, L.P.0.0%+0.00%

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Established in 2012 and headquartered in San Francisco, California, Blend Labs, Inc. provides cloud-hosted software platforms tailored for financial institutions across the United States. The company's operations are divided into two key divisions: Blend Platform and Title365. It offers a wide array of white-label solutions catering to diverse consumer financial needs, such as home mortgages, home equity loans and lines of credit, vehicle financing, personal loans, credit cards, and deposit account management. Additionally, Blend Labs supplies a specialized suite of tools designed to streamline the entire homeownership process for individuals, covering aspects like loan closing, income validation for mortgages, property insurance, and real estate services. The firm also conducts title examination processes for insurance policies, manages escrow, handles closing and settlement services, and performs various trustee duties, alongside delivering expert professional and advisory services. Its clientele encompasses a broad spectrum of financial entities, including banks, credit unions, financial technology firms, and independent mortgage providers.

Company Valuation

Slightly overvalued
3/7

Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. In particular, the stock is underpriced on P/E, of fair value on EV/EBI

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Favourable
6/7

The average target price of BLND is 2.93 and suggests 183% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incre

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

12.10.2026 00:49

What do analysts think about Trump's announced Russia-Ukraine energy ceasefire?

11.10.2026 21:01

IPO roundup: Firmus collapse sends AI funding warning; DeepSeek seeking $12 bln

11.10.2026 09:19

Twelve killed in attack on Riyadh airport

10.10.2026 16:01

Small caps last week: Webull risks, Levi’s outlook, Vaxcyte trial success

10.10.2026 13:01

How soon will the AI bubble burst? Will France infect the Eurozone? What's wrong with Levi's jeans?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026